Results for tag: "Dihydroartemisinin"

Dihydroartemisinin is a semi-synthetic derivative of artemisinin, a natural compound derived from the plant Artemisia annua. It is used in combination with other antimalarial drugs to treat and prevent malaria, a mosquito-borne infectious disease. Dihydroartemisinin is also used to treat other infectious diseases, such as schistosomiasis, a parasitic infection caused by contact with contaminated water. Dihydroartemisinin is available in both oral and injectable forms, and is often used in combination with other drugs to increase its effectiveness. It is generally well tolerated, with few side effects. However, it can cause nausea, vomiting, and diarrhea in some patients. The dihydroartemisinin market is highly competitive, with many companies offering products for the treatment and prevention of infectious diseases. Companies such as Novartis, Sanofi, and Cipla are among the leading manufacturers of dihydroartemisinin-based drugs. Other companies, such as Ranbaxy, Lupin, and Sun Pharmaceuticals, also offer dihydroartemisinin-based products. Show Less Read more